(Q44726375)

English

Impact of inhaled salmeterol/fluticasone propionate combination product versus budesonide on the health-related quality of life of patients with asthma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Impact of inhaled salmeterol/fluticasone propionate combination product versus budesonide on the health-related quality of life of patients with asthma (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

0 references

quality of life

1 reference

based on heuristic

inferred from title

Christine Jenkins

object named as

Christine Jenkins

2

0 references

author name string

Elizabeth F Juniper

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Martin J Price

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Mark H James

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Treatments in Respiratory Medicine

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

435-440

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

An evaluation of an asthma quality of life questionnaire as a measure of change in adults with asthma.

1 reference

https://api.crossref.org/works/10.1007%2FBF03257170

21 January 2018

Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol.

1 reference

https://api.crossref.org/works/10.1007%2FBF03257170

21 January 2018

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

1 reference

https://api.crossref.org/works/10.1007%2FBF03257170

21 January 2018

Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma

1 reference

https://api.crossref.org/works/10.1007%2FBF03257170

21 January 2018

Psychometric performance of the Asthma Quality of Life Questionnaire in a US sample.

1 reference

https://api.crossref.org/works/10.1007%2FBF03257170

21 January 2018

Performance of an asthma quality of life questionnaire in an outpatient setting

1 reference

https://api.crossref.org/works/10.1007%2FBF03257170

21 January 2018

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1007%2FBF03257170

21 January 2018

Asthma quality of life during 1 year of treatment with budesonide with or without formoterol.

1 reference

https://api.crossref.org/works/10.1007%2FBF03257170

21 January 2018

Interpreting treatment effects in randomised trials

1 reference

https://api.crossref.org/works/10.1007%2FBF03257170

21 January 2018

Impact of fluticasone propionate powder on health-related quality of life in patients with moderate asthma.

1 reference

https://api.crossref.org/works/10.1007%2FBF03257170

21 January 2018

Identifiers

10.1007/BF03257170

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44726375&oldid=2206871561"